Cargando…

Treatment Patterns, Healthcare Resource Utilization, and Costs Among Medicare Patients with Multiple Sclerosis in Relation to Disease-Modifying Therapy and Corticosteroid Treatment

INTRODUCTION: Despite the increasing age of the multiple sclerosis (MS) patient population, data are lacking on MS patients in later life. This retrospective study investigated treatment patterns, healthcare resource utilization (HCRU), and healthcare costs (HCCs) for patients enrolled in Medicare,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sanchirico, Marie, Caldwell-Tarr, Amanda, Mudumby, Pallavi, Hashemi, Lobat, Dufour, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6534679/ https://www.ncbi.nlm.nih.gov/pubmed/30565050 http://dx.doi.org/10.1007/s40120-018-0123-y

Ejemplares similares

A Comparison of Health Care Resource Utilization and Costs for Patients with Allergic Rhinitis on Single-Product or Free-Combination Therapy of Intranasal Steroids and Intranasal Antihistamines
por: Harrow, Brooke, et al.
Publicado: (2016)

Glucagon-Like Peptide-1 Receptor Agonist (GLP-1RA) Therapy Adherence for Patients with Type 2 Diabetes in a Medicare Population
por: Nguyen, Hiep, et al.
Publicado: (2017)

Healthcare costs and utilization for Medicare beneficiaries with Alzheimer's
por: Zhao, Yang, et al.
Publicado: (2008)

Healthcare resource utilization and costs associated with incremental systemic corticosteroid exposure in asthma
por: Voorham, Jaco, et al.
Publicado: (2018)

Mortality, healthcare resource utilization, and cost among Medicare beneficiaries with Clostridioides difficile infection with and without sepsis
por: Amin, Alpesh, et al.
Publicado: (2022)

Incident colorectal cancer screening and associated healthcare resource utilization and Medicare cost among Medicare beneficiaries aged 66–75 years in 2016–2018
por: Li, Suying, et al.
Publicado: (2022)

Treatment Patterns and Healthcare Resource Use in Medicare Beneficiaries with Parkinson’s Disease
por: Song, Yan, et al.
Publicado: (2023)

ASSOCIATION OF SENSORY AND COGNITIVE IMPAIRMENT WITH HEALTHCARE UTILIZATION AND COST IN MEDICARE BENEFICIARIES
por: Deardorff, William, et al.
Publicado: (2019)

1019. Healthcare Resource Utilization and Cost of People Living with HIV (PLWH) in US Commercial and Medicare Advantage Health Plans
por: Priest, Julie, et al.
Publicado: (2020)

Evaluating Treatment Patterns, Relapses, Healthcare Resource Utilization, and Costs Associated with Disease-Modifying Treatments for Multiple Sclerosis in DMT-Naïve Patients
por: Freeman, Leorah, et al.
Publicado: (2021)

Treatment patterns, healthcare resource utilization, and costs among patients with idiopathic pulmonary fibrosis treated with antifibrotic medications in US-based commercial and Medicare Supplemental claims databases: a retrospective cohort study
por: Corral, Mitra, et al.
Publicado: (2020)

Disaster impacts on cost and utilization of Medicare
por: Rosenheim, Nathanael, et al.
Publicado: (2018)

Healthcare utilization and costs among high-need and frail Mexican American Medicare beneficiaries
por: Rivera-Hernandez, Maricruz, et al.
Publicado: (2022)

Impact on healthcare resource utilization of multiple sclerosis in Spain
por: Sicras-Mainar, Antoni, et al.
Publicado: (2017)

Adverse Outcomes, Healthcare Resource Utilization, and Costs Associated with Systemic Corticosteroid use Among Adults with Systemic Lupus Erythematosus in the UK
por: Stirnadel-Farrant, Heide A., et al.
Publicado: (2023)

Healthcare resource use and costs of multiple sclerosis patients in Germany before and during fampridine treatment
por: Ziemssen, Tjalf, et al.
Publicado: (2017)

Healthcare Costs and Resource Utilization in Patients with Multiple Sclerosis Relapses Treated with H.P. Acthar Gel(®)
por: Gold, Laura S., et al.
Publicado: (2016)

Chronic Myeloid Leukemia: Part I—Real-World Treatment Patterns, Healthcare Resource Utilization, and Associated Costs in Later Lines of Therapy in the United States
por: Atallah, Ehab L., et al.
Publicado: (2022)

Impact of Oxycodone HCl Extended-release Formulary Restrictions on Extended-release Opioid Market Share, Healthcare Resource Utilization and Costs in Commercial and Medicare Plans
por: Wade, Rolin L., et al.
Publicado: (2017)

Impact of Medicare SELECT on Cost and Utilization in 11 States
por: Lee, A. James, et al.
Publicado: (1997)

The Association Between Persistence and Adherence to Disease-Modifying Therapies and Healthcare Resource Utilization and Costs in Patients With Multiple Sclerosis
por: Pardo, Gabriel, et al.
Publicado: (2022)

Impact of Medicare payment policy on home health resources utilization
por: Irvine, Audrey, et al.
Publicado: (1991)

Burden of rheumatoid arthritis among US Medicare population: co-morbidities, health-care resource utilization and costs
por: Chen, Chieh-I, et al.
Publicado: (2018)

Impact of comorbid conditions in COPD patients on health care resource utilization and costs in a predominantly Medicare population
por: Schwab, Phil, et al.
Publicado: (2017)

Impact of Endometriosis Diagnostic Delays on Healthcare Resource Utilization and Costs
por: Surrey, Eric, et al.
Publicado: (2020)

Healthcare resource utilization and costs associated with anogenital warts in Morocco
por: Berrada, Myriam, et al.
Publicado: (2021)

Prevalence, treatment patterns, and healthcare resource utilization in Medicare and commercially insured non-dialysis-dependent chronic kidney disease patients with and without anemia in the United States
por: St. Peter, Wendy L., et al.
Publicado: (2018)

Healthcare resource utilization and costs for multiple sclerosis management in the Campania region of Italy: Comparison between centre-based and local service healthcare delivery
por: Moccia, Marcello, et al.
Publicado: (2019)

Effectiveness of Medicare cost-sharing elimination for Cancer screening on utilization
por: Xu, Wendy Yi, et al.
Publicado: (2019)

Trends in the Cost and Utilization of Omalizumab in the Medicare Population: 2013-2017
por: Cheraghlou, Shayan, et al.
Publicado: (2022)

Epidemiology, treatment patterns and healthcare utilizations in multiple sclerosis in Taiwan
por: Hsu, Chia-Yun, et al.
Publicado: (2021)

Analysis of Healthcare Resource Utilization and Costs after the Initiation of Biologic Treatment in Patients with Ulcerative Colitis and Crohn’s Disease
por: Perera, Sue, et al.
Publicado: (2018)

Treatment patterns, healthcare resource utilization, and healthcare costs among patients with pulmonary arterial hypertension in a real-world US database
por: Studer, Sean, et al.
Publicado: (2018)

Healthcare Resource Utilization and Cost of Invasive Meningococcal Disease in Ontario, Canada
por: Rampakakis, Emmanouil, et al.
Publicado: (2019)

Colorectal cancer-related resource utilization and healthcare costs in Saudi Arabia
por: Balkhi, Bander, et al.
Publicado: (2023)

Colon Cancer Treatment Costs for Medicare and Dually Eligible Beneficiaries
por: Luo, Zhehui, et al.
Publicado: (2009)

Cost-Related Medication Nonadherence (CRN) on Healthcare Utilization and Patient-Reported Outcomes: Considerations in Managing Medicare Beneficiaries on Antidepressants
por: Alnijadi, Abdulrahman A., et al.
Publicado: (2021)

Immune checkpoint inhibitors: immune-related adverse events, healthcare utilization, and costs among commercial and Medicare Advantage patients
por: Gunturu, Krishna S., et al.
Publicado: (2022)

1691. Pre- and Post-Hospitalization Resource Utilization and Costs Associated with Urinary Tract Infection (UTI) in both Commercial and Medicare Populations
por: Melnick, David, et al.
Publicado: (2020)

Real‐world treatment patterns, healthcare resource utilization, and cost among adults with pulmonary arterial hypertension in the United States
por: Pizzicato, Lia N., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_na1lc8mr50dqpplg0h7ebc8b5g